An early winter blast has many local businesses and organizations closed Monday. Check out this list to see if you really ...

Kezar Life Sciences has become the latest biotech to decide that it could do better than a buyout offer from Concentra Biosciences. Concentra’s parent company Tang Capital Partners has a track ...

(RTTNews) - Kezar Life Sciences (KZR) announced that its Board has rejected the unsolicited, non-binding proposal from Concentra Biosciences, to acquire all of the outstanding shares of common ...

Earlier on Thursday, Kezar Life Sciences rejected the previously disclosed unsolicited, non-binding proposal from Concentra Biosciences for cash consideration of $1.10 per share, plus a contingent ...

1 Day CON 0.52% DJIA 0.09% S&P Mid Cap 400 0.01% Health Care/Life Sciences 0.22% ...

1 Day CON -2.54% DJIA 0.37% S&P Mid Cap 400 0.15% Health Care/Life Sciences -0.15% ...

RichDX®, best known for its Revolution Sample Prep Systemtm for liquid biopsy, will display its latest products, present new data, and exhibit at the Association for Molecular Pathology (AMP) Annual ...

Oct. 21, 2024 — Updated clinical recommendations, including lifestyle changes, prevention strategies and treatment options, to reduce the risk of a first stroke have ... Big Data, Real World ...